Traders should review the full 20-F filing for actual financial performance; the absence of financial data in the press release suggests no material earnings surprise. Pipeline developments remain key long-term catalysts.
Price Chart
Executive Summary
Sol-Gel Technologies filed its 20-F for 2025, disclosing audited financial results and providing corporate updates. The press release highlights pipeline progress but omits specific financial figures such as revenue, EPS, or guidance, limiting immediate financial assessment.
Key Facts
- Filed annual report on Form 20-F for fiscal year ended December 31, 2025
- No financial figures (revenue, EPS, margins) disclosed in the press release
- Lead candidate SGT-610 in Phase 3 for Gorlin syndrome, with orphan and breakthrough designation
- SGT-210 in development as a topical EGFR inhibitor
- Marketed products include TWYNEO® and EPSOLAY®
Financial Impact
Unknown — no financial results provided in press release
Risk Factors
- Lack of disclosed financials limits ability to assess operational performance
- Biotech pipeline risk for SGT-610 and SGT-210, including regulatory and clinical trial risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259020 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 6-K | $75.64 | awaiting T+20 | — | $69.63 (−7.95%) |
Sep 30, 2026 26d ago | 6-K | $74.28 | awaiting T+20 | — | $69.63 (−6.26%) |
Sep 17, 2026 5w ago | 6-K | $64.54 $68.70 | ▲ +6.45% | ▲ +4.99% | $69.63 (+7.89%) |
Sep 14, 2026 6w ago | Insider Buy | $64.40 $68.30 | ▲ +6.06% | ▲ +3.08% | $69.63 (+8.12%) |
Sep 9, 2026 6w ago | Insider Buy | $66.79 $70.34 | ▲ +5.32% | ▲ +2.94% | $69.63 (+4.25%) |
Sep 3, 2026 7w ago | Insider Buy | $69.52 $78.95 | ▲ +13.56% | ▲ +12.96% | $69.63 (+0.16%) |
Aug 31, 2026 8w ago | Insider Buy | $69.52 $74.28 | ▲ +6.85% | ▲ +6.53% | $69.63 (+0.16%) |
Aug 20, 2026 9w ago | 6-K | $78.50 $64.54 | ▼ −17.78% | ▼ −17.78% | $69.63 (−11.29%) |
Aug 20, 2026 9w ago | Press Release | $78.50 $64.54 | ▼ −17.78% | ▼ −17.78% | $69.63 (−11.29%) |
Aug 14, 2026 10w ago | Insider Buy | $83.01 $64.40 | ▼ −22.42% | ▼ −20.44% | $69.63 (−16.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers